{
    "2020-04-20": [
        [
            {
                "time": "",
                "original_text": "智飞生物多项疫苗产品取得阶段性进展",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "疫苗",
                        "阶段性进展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：2019年净利同比增63% 拟10派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利",
                        "同比增",
                        "派息"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)2019年度净利润升63.05%至23.66亿元 拟10派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润",
                        "同比上升",
                        "派息"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：2019年净利润同比增长63.05%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【朝闻国盛0421】融资成本改善，疫情防控债存预期差",
                "features": {
                    "keywords": [
                        "融资成本",
                        "改善",
                        "疫情防控债",
                        "预期差"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "债券市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}